Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02009930 · ClinicalTrials.gov registry record
Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.
- Terminated
- Registry status
- 112
- Enrollment target
NCT02009930: Clinical Trial study, sponsored by David Grant U.S. Air Force Medical Center.
NCT02009930 is a clinical trial that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02009930 was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.
- TERMINATED
- Registry status
- 112 participants
- Enrollment target
Study Summary
Hypothesis: Enlisted military members with 10 or more years of service and at least one cardiovascular risk factor will demonstrate a higher risk of future cardiac events as assessed by coronary artery calcium (CAC) scoring than the risk calculated by the Framingham Risk Score.
Primary Outcome
Percent of active duty enlisted military members with 10 or more years of military service determined to have a prevalence of atherosclerosis based on CAC risk category. The CAC risk category (scale), is derived from the CAC score (i.e., an estimate of the degree of atherosclerosis present in each participant's coronary arteries, reported as a number), and percentage by age to establish risk of future CV events. There are 5 risk categories: Low risk = CAC of 0 and no cardiovascular (CV) risk fac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2013-11-05 |
| Est. Completion | 2018-07-18 |
Why NCT02009930 stopped before completion
NCT02009930 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02009930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02009930 about?
NCT02009930 is a clinical study titled "Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service". Hypothesis: Enlisted military members with 10 or more years of service and at least one cardiovascular risk factor will demonstrate a higher risk of future cardiac events as assessed by coronary artery calcium (CAC) scoring than the risk calculated by the Framingham Risk Score.
What is the current status of trial NCT02009930?
This trial is currently terminated. The enrollment target is 112 participants. The study started on 2013-11-05. Estimated completion is 2018-07-18.
Who is sponsoring clinical trial NCT02009930?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI